Incidence of human immunodeficiency virus antibody in a prenatal population at a community hospital.
Prenatal human immunodeficiency virus (HIV) screening may reduce vertical HIV transmission. We screened 4,419 prenatal sera and found 38 repeatedly reactive specimens with an HIV-1-HIV-2 enzyme-linked immunosorbent assay. Western blot analysis confirmed four of these specimens as positive for HIV-1 antibodies. Screening detects previously unidentified HIV infections, but false-positive results may also occur.
Alexander
T S
TS
Department of Pathology and Laboratory Medicine, Summa Health System, Akron, Ohio 44304, USA. alexandt@summa-health.org
Lee
J
J
Yen-Lieberman
B
B
D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D006679:HIV Seropositivity / Q000150:complications* / Q000453:epidemiology* / Q000635:transmission; D015497:HIV-1; D006764:Hospitals, Community; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008403:Mass Screening; D009820:Ohio / Q000453:epidemiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology*
D015483:HIV Antibodies